Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DX Other systemic drugs for obstructive airway diseases
R03DX05 Omalizumab
D05251 Omalizumab (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Immunological Agents, Other
Immunological Agents, Miscellaneous
Omalizumab
D05251 Omalizumab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D05251 Omalizumab (USAN/INN); Omalizumab (genetical recombination) (JAN)
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D05251 Omalizumab (USAN/INN); Omalizumab (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Immune system
FCER1A
D05251 Omalizumab (USAN/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05251
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05251
